---
name: PozeSCAF Inc.
slug: pozescaf-discovery-solutions
site: cro
website_domain: pozescaf.com
summary: Preclinical drug discovery CRO combining proprietary generative AI platform AxDrug with computational chemistry, synthetic chemistry, and in vitro biology to accelerate hit discovery and lead optimization for biotech and pharma clients.
tagline: AI-powered preclinical drug discovery combining generative AI, computational chemistry, and synthesis.
founded_year: 2019
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: 
tier2_domain_verified: false
updated_at: 2026-08-03T07:01:43.287Z
services_count: 5
modalities_count: 3
indications_count: 0
locations_count: 0
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# PozeSCAF Inc.

AI-powered preclinical drug discovery combining generative AI, computational chemistry, and synthesis.

Listed on cro.directory.

## Summary

Preclinical drug discovery CRO combining proprietary generative AI platform AxDrug with computational chemistry, synthetic chemistry, and in vitro biology to accelerate hit discovery and lead optimization for biotech and pharma clients.

## At a glance

- Founded: 2019

## Services

- Computational & In-Silico Drug Discovery
- Target Identification & Validation
- High-Throughput Screening
- Medicinal Chemistry
- Discovery Research

## Modalities

- Small Molecule
- Peptide
- Antibody-Drug Conjugate (ADC)

## Long description

## Overview

PozeSCAF Inc. (formerly Immunocure Inc., founded 2019) is a preclinical drug discovery CRO that integrates its proprietary AxDrug AI platform with computational chemistry, medicinal chemistry synthesis, and in vitro biology services. The company serves biotech and pharmaceutical clients seeking to accelerate small-molecule drug discovery from target validation through lead optimization.

## Core Capabilities

**Computational Chemistry & AI Services:**
- Target validation and druggability prediction
- Hit identification via virtual screening of 20+ billion compound databases using generative AI and consensus docking models
- Hit-to-lead generation with scaffold hopping, enumeration, and binding affinity prediction based on quantum mechanics
- Lead optimization using multi-parameter AI protocols, molecular dynamics simulations, and free energy perturbation (FEP) studies
- ADME and toxicity prediction models
- Off-target prediction and polypharmacology assessment
- Custom AI model generation (data curation, preparation, and integration)

**Synthesis & Chemistry:**
- Small-molecule synthesis (milligrams to kilograms)
- Custom peptide synthesis
- PROTAC design and synthesis
- Molecular glue design
- Medicinal chemistry optimization and structure-activity relationship (SAR) insights

**In Vitro Biology (New):**
- Biochemical assay services
- Cell-based assay services
- Advanced in vitro models for drug discovery

## Differentiation

PozeSCAF emphasizes seamless integration between AI-driven design and in-house synthesis, eliminating handoffs and delays. The company leverages a 20+ billion compound database generated through generative AI and commercial libraries, advanced machine learning and deep learning frameworks, and molecular dynamics with enhanced protocols. The team combines computational expertise with experienced medicinal and synthetic chemists to reduce R&D costs and timelines for clients.

## Related companies

- [Aurigene Pharmaceutical Services Limited](/companies/aurigeneservices) (Computational & In-Silico Drug Discovery, Target Identification & Validation) — [Compare](/compare/aurigeneservices/pozescaf-discovery-solutions)
- [Beantown Biotech](/companies/beantownbiotech) (Computational & In-Silico Drug Discovery, Target Identification & Validation) — [Compare](/compare/beantownbiotech/pozescaf-discovery-solutions)
- [BioDuro-Sundia](/companies/bioduro-sundia) (Computational & In-Silico Drug Discovery, Target Identification & Validation) — [Compare](/compare/bioduro-sundia/pozescaf-discovery-solutions)
- [ChemPartner](/companies/chempartner) (Computational & In-Silico Drug Discovery, Target Identification & Validation) — [Compare](/compare/chempartner/pozescaf-discovery-solutions)
- [Axxam](/companies/axxam) (Target Identification & Validation, High-Throughput Screening) — [Compare](/compare/axxam/pozescaf-discovery-solutions)
- [ResolveMass Laboratories Inc.](/companies/resolvemass) (Medicinal Chemistry, Small Molecule) — [Compare](/compare/pozescaf-discovery-solutions/resolvemass)
- [Aragen Life Sciences](/companies/aragen) (Computational & In-Silico Drug Discovery, Target Identification & Validation) — [Compare](/compare/aragen/pozescaf-discovery-solutions)
- [Certara](/companies/certara) (Computational & In-Silico Drug Discovery, Target Identification & Validation) — [Compare](/compare/certara/pozescaf-discovery-solutions)

_Profile last updated: 2026-08-03T07:01:43.287Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.